Global /Australia /Healthcare /Medical Devices /AT1

Atomo Diagnostics Ltd.

AT1

• ASX: AT1 • Delayed

0.0240AUD -7.7%

0.0169 USD

As of 8 June 2026, Atomo Diagnostics Ltd. has a market cap of $16.52M USD, ranking #38324 globally and #1157 in Australia. It ranks #3420 in the Healthcare sector, and #726 in the Medical Devices industry.

Global Rank

38324

Country Rank

1157

Sector Rank

3420

Industry Rank

726

Key Stats

Market Cap

$16.52MUSD

23.43M AUD

Enterprise Value

$14.38MUSD

20.42M AUD

Revenue (TTM)

$2.76MUSD

3.92M AUD

EBITDA (TTM)

-$3.14MUSD

-4.46M AUD

Net Income (TTM)

-$2.8MUSD

-3.98M AUD

EBITDA Margin

-114%

Profit Margin

-101%

PS Ratio

6.0

PB Ratio

3.5

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

John Kelly open_in_new

Employees

Founded

2010

Website

atomodiagnostics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-7.7%	-3.7%	-35%	-30%	-7.1%	-28%	44%	-26%	-87%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	AT1 Atomo Diagnostics Ltd Ordinary Shares ISIN: AU0000080327 Shares Out.: Shares Outstanding: 902.433M¹ Shares Float: 810.593M² TV: TradingView: ASX: AT1 SA: Stock Analysis: ASX: AT1 YF: Yahoo Finance: AT1.AX GF: Google Finance: ASX: AT1 BA: Barron's: AT1 MS: Morningstar: XASX: AT1	0.0240 AUD	TV: TradingView: ASX: AT1 SA: Stock Analysis: ASX: AT1 YF: Yahoo Finance: AT1.AX GF: Google Finance: ASX: AT1 BA: Barron's: AT1 MS: Morningstar: XASX: AT1

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Atomo Diagnostics Ltd.

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.15B 5.89B AUD 25K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.52B 4.34B NZD 15K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$777.05M 1.1B AUD 5K%	-	Australia
Nanosonics Ltd. ASX: NAN	$734.34M 1.04B AUD 4K%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$168.98M 239.61M AUD 923%	-	Australia
Orthocell Ltd. ASX: OCC	$168.37M 238.75M AUD 919%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 1M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 973K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 963K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 766K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 730K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 617K%	22.2	Ireland

chevron_leftBack